Stabilized solid pharmaceutical preparations in which one or more of sodium carbonate, sodium hydrogen carbonate, calcium carbonate and calcium hydrogen phosphate are incorporated in a solid composition containing a 1,4-dihydropyridine derivative as an active ingredient. The present compositions are used as an oral therapeutic agent for the circulatory system, especially as a coronary vasodilator.